Coexistence of the BRCA1 and KRAS mutations in a patient with salivary gland carcinoma arising in mediastinal mature teratoma

Anticancer Drugs. 2020 Sep;31(8):876-879. doi: 10.1097/CAD.0000000000000958.

Abstract

Teratoma with malignant transformation is a rare type of malignant teratoma. In the present case, we describe a patient with salivary gland carcinoma (SGC) generating in mediastinal mature teratoma. Next-generation sequencing showed BRCA1 and KRAS somatic mutations, which might be associated with malignant transformation of the mediastinal mature teratomas. To our knowledge, the present case is the first report of coexistence of BRCA1 and KRAS mutations in mature cystic teratoma with malignant transformation to SGC. And the tumor showed a good response to chemotherapy with cisplatin and paclitaxel according to the transformed histology.

Publication types

  • Case Reports

MeSH terms

  • BRCA1 Protein / genetics*
  • Humans
  • Male
  • Mediastinal Neoplasms / drug therapy
  • Mediastinal Neoplasms / genetics
  • Mediastinal Neoplasms / pathology*
  • Middle Aged
  • Mutation*
  • Prognosis
  • Proto-Oncogene Proteins p21(ras) / genetics*
  • Salivary Gland Neoplasms / drug therapy
  • Salivary Gland Neoplasms / genetics
  • Salivary Gland Neoplasms / secondary*
  • Teratoma / drug therapy
  • Teratoma / genetics
  • Teratoma / pathology*

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)